{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T02:00:57Z","timestamp":1780192857784,"version":"3.54.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100032767","name":"Sichuan Medical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.118960","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:48:31Z","timestamp":1779205711000},"page":"118960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Natural PDE4 inhibitors from plants: A comprehensive review of discovery, structure-activity relationships, and clinical translation potential"],"prefix":"10.1016","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-4681","authenticated-orcid":false,"given":"Hao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118960_bib1","article-title":"Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the global burden of disease study 2019","volume":"59","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejmech.2026.118960_bib2","series-title":"Chronic Respiratory Diseases: Asthma","author":"Organization","year":"2024"},{"key":"10.1016\/j.ejmech.2026.118960_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","article-title":"Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial","volume":"366","author":"Rabe","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118960_bib4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/annrheumdis-2013-205056","article-title":"Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor","volume":"73","author":"Kavanaugh","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2026.118960_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118960_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112230","article-title":"Best practice in research - overcoming common challenges in phytopharmacological research","volume":"246","author":"Heinrich","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2026.118960_bib7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.118960_bib8","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118960_bib9","first-page":"19","article-title":"Phosphodiesterase inhibitors of natural origin","volume":"14","author":"Rui","year":"2024","journal-title":"Nat. Prod. J."},{"key":"10.1016\/j.ejmech.2026.118960_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2026.118960_bib11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2026.118960_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pupt.2010.03.011","article-title":"The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease","volume":"23","author":"Hatzelmann","year":"2010","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.118960_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002130000414","article-title":"Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats","volume":"150","author":"Zhang","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2026.118960_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1523\/JNEUROSCI.5236-10.2011","article-title":"Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling","volume":"31","author":"Li","year":"2011","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejmech.2026.118960_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-540-72843-6_6","article-title":"PDE4 associates with different scaffolding proteins: modulating interactions as treatment for certain diseases","author":"McCahill","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118960_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2026.118960_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118960_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.118960_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.202306-0944OC","article-title":"Ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor for the treatment of chronic obstructive pulmonary disease: randomized, double-blind, placebo-controlled, multicenter phase III trials (the ENHANCE trials)","volume":"208","author":"Anzueto","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2026.118960_bib20","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1074\/jbc.R200029200","article-title":"Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling","volume":"278","author":"Conti","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118960_bib21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjp.0703636","article-title":"Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases","volume":"131","author":"Baillie","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118960_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158052","article-title":"PDE4D: a multipurpose pharmacological target","volume":"25","author":"Lusardi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118960_bib23","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1021\/acs.jmedchem.9b02170","article-title":"Advances in the development of Phosphodiesterase-4 inhibitors","volume":"63","author":"Peng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118960_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1476-5381.2011.01218.x","article-title":"Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease","volume":"163","author":"Rabe","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118960_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","article-title":"Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials","volume":"374","author":"Calverley","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118960_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107826","article-title":"Cyclic nucleotide phosphodiesterase inhibitors as therapeutic interventions for cystic fibrosis","volume":"224","author":"Turner","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.118960_bib27","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.118960_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ph18101507","article-title":"The emerging role of phosphodiesterase inhibitors in fragile X syndrome and autism spectrum disorder","volume":"18","author":"Thomas","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118960_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117009","article-title":"Beyond PDE4 inhibition: a comprehensive review on downstream cAMP signaling in the central nervous system","volume":"177","author":"Donders","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118960_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","article-title":"Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults","volume":"75","author":"Paller","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejmech.2026.118960_bib31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","article-title":"Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis","volume":"110","author":"Robichaud","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.118960_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bjp.0704457","article-title":"Assessing the emetic potential of PDE4 inhibitors in rats","volume":"135","author":"Robichaud","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118960_bib33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2022.15632","article-title":"Effect of roflumilast cream vs vehicle cream on chronic plaque psoriasis: the DERMIS-1 and DERMIS-2 randomized clinical trials","volume":"328","author":"Lebwohl","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2026.118960_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamadermatol.2025.1136","article-title":"Roflumilast foam, 0.3%, for psoriasis of the scalp and body: the ARRECTOR phase 3 randomized clinical trial","volume":"161","author":"Gooderham","year":"2025","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ejmech.2026.118960_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/17425255.2024.2337749","article-title":"Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients","volume":"20","author":"Lo","year":"2024","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejmech.2026.118960_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bjd.20655","article-title":"Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial","volume":"186","author":"Saeki","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejmech.2026.118960_bib36","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in patients with idiopathic pulmonary fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.118960_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-2600(13)70187-5","article-title":"Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials","volume":"1","author":"Franciosi","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2026.118960_bib38","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41591-021-01321-w","article-title":"Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial","volume":"27","author":"Berry-Kravis","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.118960_bib39","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1021\/acs.jmedchem.9b00193","article-title":"Design and synthesis of selective phosphodiesterase 4D (PDE4D) allosteric inhibitors for the treatment of fragile X syndrome and other brain disorders","volume":"62","author":"Gurney","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118960_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/BF01965408","article-title":"Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships","volume":"12","author":"Beretz","year":"1982","journal-title":"Agents Actions"},{"key":"10.1016\/j.ejmech.2026.118960_bib42","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.bcp.2004.06.030","article-title":"Inhibitory effects of flavonoids on phosphodiesterase isozymes from Guinea pig and their structure-activity relationships","volume":"68","author":"Ko","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118960_bib53","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0006-2952(79)90249-1","article-title":"Flavonoids are selective cyclic GMP phosphodiesterase inhibitors","volume":"28","author":"Ruckstuhl","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118960_bib43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2003-38874","article-title":"3-O-methylquercetin more selectively inhibits phosphodiesterase subtype 3","volume":"69","author":"Ko","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2026.118960_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-2005-837774","article-title":"Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+\/-)-naringenin","volume":"71","author":"Orallo","year":"2005","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2026.118960_bib54","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1021\/acs.jmedchem.1c02058","article-title":"Discovery and structural optimization of toddacoumalone derivatives as novel PDE4 inhibitors for the topical treatment of psoriasis","volume":"65","author":"Song","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118960_bib45","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.jmedchem.0c00060","article-title":"Discovery and optimization of alpha-Mangostin derivatives as novel PDE4 inhibitors for the treatment of vascular dementia","volume":"63","author":"Liang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118960_bib55","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1080\/14786419.2017.1300796","article-title":"Bioactive triterpenoids from the leaves of Eriobotrya japonica as the natural PDE4 inhibitors","volume":"31","author":"Tan","year":"2017","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2026.118960_bib56","first-page":"E1414","article-title":"Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4","volume":"112","author":"Cedervall","year":"2015"},{"key":"10.1016\/j.ejmech.2026.118960_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1165\/rcmb.2013-0133OC","article-title":"Active components of ginger potentiate beta-agonist-induced relaxation of airway smooth muscle by modulating cytoskeletal regulatory proteins","volume":"50","author":"Townsend","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118960_bib51","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/j.bmcl.2012.03.026","article-title":"Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor","volume":"22","author":"Chen","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118960_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2017.01.016","article-title":"The discovery, complex crystal structure, and recognition mechanism of a novel natural PDE4 inhibitor from Selaginella pulvinata","volume":"130","author":"Huang","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118960_bib47","first-page":"27","article-title":"Anticholinesterase effects of huperzine A, E2020, and tacrine in rats","volume":"19","author":"Wang","year":"1998","journal-title":"Zhongguo Yaoli Xuebao"},{"key":"10.1016\/j.ejmech.2026.118960_bib48","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2026.118960_bib50","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","article-title":"Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates","volume":"21","author":"Doak","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118960_bib52","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2026.118960_bib57","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1039\/c004698c","article-title":"The biological potential of flavones","volume":"27","author":"Verma","year":"2010","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2026.118960_bib58","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/12081641","article-title":"Flavonoid composition of Citrus juices","volume":"12","author":"Gattuso","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118960_bib59","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1021\/ol061147j","article-title":"Pd\/C-catalyzed chemoselective hydrogenation in the presence of diphenylsulfide","volume":"8","author":"Mori","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.118960_bib60","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1021\/cr00039a007","article-title":"Palladium-catalyzed cross-coupling reactions of organoboron compounds","volume":"95","author":"Miyaura","year":"1995","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.118960_bib61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2003-37500","article-title":"Dose-dependent stimulation of melatonin secretion after administration of Agnus castus","volume":"111","author":"Dericks-Tan","year":"2003","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ejmech.2026.118960_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11240-014-0467-7","article-title":"Production of secondary metabolites from cell and organ cultures: strategies and approaches for biomass improvement and metabolite accumulation","volume":"118","author":"Murthy","year":"2014","journal-title":"Plant Cell Tissue Organ Cult."},{"key":"10.1016\/j.ejmech.2026.118960_bib63","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1039\/c0cp02302g","article-title":"Monitoring the effect of a control pulse on a conical intersection by time-resolved photoelectron spectroscopy","volume":"13","author":"Arasaki","year":"2011","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejmech.2026.118960_bib64","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3390\/molecules14062016","article-title":"Pentacyclic triterpene distribution in various plants - rich sources for a new group of multi-potent plant extracts","volume":"14","author":"Jager","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118960_bib65","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1021\/jm0002230","article-title":"Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages","volume":"43","author":"Honda","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118960_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020250","article-title":"Coumarin: a natural, privileged and versatile scaffold for bioactive compounds","volume":"23","author":"Stefanachi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118960_bib67","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1021\/ol070406h","article-title":"An efficient waste-free oxidative coupling via regioselective C-H bond cleavage: Rh\/Cu-catalyzed reaction of benzoic acids with alkynes and acrylates under air","volume":"9","author":"Ueura","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.118960_bib68","doi-asserted-by":"crossref","first-page":"11506","DOI":"10.1021\/ja035121o","article-title":"1,4-palladium migration via C-H activation, followed by arylation: synthesis of fused polycycles","volume":"125","author":"Campo","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118960_bib69","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1002\/anie.201708408","article-title":"Directed evolution: bringing new chemistry to life","volume":"57","author":"Arnold","year":"2018","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2026.118960_bib70","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.biotechadv.2014.10.012","article-title":"Microbial biotransformation of bioactive flavonoids","volume":"33","author":"Cao","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2026.118960_bib71","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cellsig.2013.12.003","article-title":"Structural basis for the design of selective phosphodiesterase 4B inhibitors","volume":"26","author":"Fox","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2026.118960_bib72","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/ijms11041321","article-title":"Bioavailability of the polyphenols: status and controversies","volume":"11","author":"D'Archivio","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118960_bib73","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0014-5793(97)01367-7","article-title":"Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man","volume":"418","author":"Hollman","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2026.118960_bib74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s13346-012-0063-5","article-title":"Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model","volume":"2","author":"Chitkara","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejmech.2026.118960_bib75","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/21691401.2019.1573739","article-title":"Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability","volume":"47","author":"Qiu","year":"2019","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.118960_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202400980","article-title":"Luteolin-loaded hyaluronidase nanoparticles with deep tissue penetration capability for idiopathic pulmonary fibrosis treatment","volume":"9","author":"Pan","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.ejmech.2026.118960_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122375","article-title":"Development and assessment of phospholipid-based luteolin-loaded lipid nanocapsules for skin delivery","volume":"629","author":"Elmowafy","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2026.118960_bib78","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1007\/s13346-023-01338-3","article-title":"Exploring the potential of quercetin\/aspirin-loaded chitosan nanoparticles coated with Eudragit L100 in the treatment of induced-colorectal cancer in rats","volume":"13","author":"Elmowafy","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejmech.2026.118960_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2020.112887","article-title":"Enhancement of phenylpropanoid accumulation in tartary buckwheat hairy roots by overexpression of MYB transcription factors","volume":"156","author":"Li","year":"2020","journal-title":"Ind. Crop. Prod."},{"key":"10.1016\/j.ejmech.2026.118960_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2024.1520543","article-title":"UV-B induced flavonoid accumulation and related gene expression in blue- grained wheat at different periods of time","volume":"15","author":"Li","year":"2024","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.ejmech.2026.118960_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153806","article-title":"Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1\/FASN-driven metabolism and AR","volume":"93","author":"Hsieh","year":"2021","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"key":"10.1016\/j.ejmech.2026.118960_bib82","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00425-017-2730-8","article-title":"Regulation of stilbene biosynthesis in plants","volume":"246","author":"Dubrovina","year":"2017","journal-title":"Planta"},{"key":"10.1016\/j.ejmech.2026.118960_bib83","article-title":"Enhancing flavonoid production by systematically tuning the central metabolic pathways based on a CRISPR interference system in Escherichia coli","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118960_bib84","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1021\/acs.jafc.7b02507","article-title":"Enhancement of naringenin biosynthesis from tyrosine by metabolic engineering of Saccharomyces cerevisiae","volume":"65","author":"Lyu","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2026.118960_bib85","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/07388550601173918","article-title":"Hairy root culture for mass-production of high-value secondary metabolites","volume":"27","author":"Srivastava","year":"2007","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.118960_bib86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.plantsci.2009.05.012","article-title":"Metabolism and roles of stilbenes in plants","volume":"177","author":"Chong","year":"2009","journal-title":"Plant Sci."},{"key":"10.1016\/j.ejmech.2026.118960_bib87","article-title":"Bioactive benzofuran derivatives from cortex mori radicis, and their neuroprotective and analgesic activities mediated by mGluR(1)","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118960_bib88","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/anie.201000044","article-title":"Plant polyphenols: chemical properties, biological activities, and synthesis","volume":"50","author":"Quideau","year":"2011","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2026.118960_bib89","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/0973-1296.137362","article-title":"Efficient production of flavonoids in Fagopyrum tataricum hairy root cultures with yeast polysaccharide elicitation and medium renewal process","volume":"10","author":"Zhao","year":"2014","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.ejmech.2026.118960_bib90","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nature04640","article-title":"Production of the antimalarial drug precursor artemisinic acid in engineered yeast","volume":"440","author":"Ro","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118960_bib91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-019-0978-9","article-title":"Complete biosynthesis of cannabinoids and their unnatural analogues in yeast","volume":"567","author":"Luo","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118960_bib92","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ymben.2011.09.002","article-title":"Cell-free synthetic biology: thinking outside the cell","volume":"14","author":"Hodgman","year":"2012","journal-title":"Metab. Eng."},{"key":"10.1016\/j.ejmech.2026.118960_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13321-020-00478-9","article-title":"COCONUT online: collection of open Natural products database","volume":"13","author":"Sorokina","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2026.118960_bib94","doi-asserted-by":"crossref","first-page":"D634","DOI":"10.1093\/nar\/gkae1063","article-title":"Coconut 2.0: a comprehensive overhaul and curation of the collection of open natural products database","volume":"53","author":"Chandrasekhar","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.118960_bib95","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118960_bib96","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41592-022-01685-y","article-title":"AlphaFill: enriching AlphaFold models with ligands and cofactors","volume":"20","author":"Hekkelman","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2026.118960_bib97","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1038\/s41467-023-43681-6","article-title":"Accurate prediction of protein assembly structure by combining AlphaFold and symmetrical docking","volume":"14","author":"Jeppesen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118960_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ddtec.2020.11.009","article-title":"A compact review of molecular property prediction with graph neural networks","volume":"37","author":"Wieder","year":"2020","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2026.118960_bib99","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1021\/acs.jmedchem.9b00959","article-title":"Pushing the boundaries of molecular representation for drug discovery with the graph attention mechanism","volume":"63","author":"Xiong","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118960_bib100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70780","article-title":"The LOTUS initiative for open knowledge management in natural products research","volume":"11","author":"Rutz","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.118960_bib101","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.jcim.9b00237","article-title":"Analyzing learned molecular representations for property prediction","volume":"59","author":"Yang","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118960_bib102","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1021\/acs.jcim.0c00915","article-title":"Reinvent 2.0: an AI Tool for De Novo Drug Design","volume":"60","author":"Blaschke","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118960_bib103","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","article-title":"Automatic chemical design using a data-driven continuous representation of molecules","volume":"4","author":"Gomez-Bombarelli","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2026.118960_bib104","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13321-024-00812-5","article-title":"Reinvent 4: modern AI-driven generative molecule design","volume":"16","author":"Loeffler","year":"2024","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2026.118960_bib105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1021\/ci700286x","article-title":"Natural product-likeness score and its application for prioritization of compound libraries","volume":"48","author":"Ertl","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118960_bib106","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1021\/acs.jcim.0c00174","article-title":"The synthesizability of molecules proposed by generative models","volume":"60","author":"Gao","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118960_bib107","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10822-020-00314-0","article-title":"Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions","volume":"34","author":"Rodriguez-Perez","year":"2020","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2026.118960_bib108","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41570-022-00363-z","article-title":"CACHE (Critical assessment of computational Hit-finding experiments): a public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding","volume":"6","author":"Ackloo","year":"2022","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.ejmech.2026.118960_bib109","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/jpet.114.220541","article-title":"CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration","volume":"352","author":"Moretto","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.118960_bib110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12931-019-1142-7","article-title":"Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD","volume":"20","author":"Singh","year":"2019","journal-title":"Respir. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T01:27:59Z","timestamp":1780190879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":110,"alternative-id":["S0223523426004058"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118960","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural PDE4 inhibitors from plants: A comprehensive review of discovery, structure-activity relationships, and clinical translation potential","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118960"}}